Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC. - Xu X; Chen X; Xu R; Huo Z; Li C; Nowsheen S; Aziz K; Yao F; Lou Z; Deng M (Nature communications, 2026)